Tower Research Capital LLC (TRC) - ACLARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,208
+133.2%
4,264
+253.0%
0.00%
Q2 2023$12,527
+73588.2%
1,208
-41.9%
0.00%
-100.0%
Q1 2023$17
+70.0%
2,078
+224.7%
0.00%
Q4 2022$10
-100.0%
640
-91.9%
0.00%
-100.0%
Q3 2022$125,000
-32.1%
7,931
-39.9%
0.00%
-50.0%
Q2 2022$184,000
+736.4%
13,200
+915.4%
0.00%
Q1 2022$22,0000.0%1,300
-10.4%
0.00%
Q4 2021$22,000
-81.7%
1,451
-78.2%
0.00%
-100.0%
Q3 2021$120,000
-19.5%
6,670
-21.1%
0.00%
-25.0%
Q2 2021$149,000
+776.5%
8,457
+1123.9%
0.00%
Q1 2021$17,000
+750.0%
691
+153.1%
0.00%
Q4 2020$2,000273
+25.2%
0.00%
Q4 2019$0
-100.0%
218
-96.2%
0.00%
Q3 2019$7,000
+16.7%
5,774
+510.4%
0.00%
Q1 2019$6,000
-14.3%
946
+103.9%
0.00%
-100.0%
Q3 2018$7,000
+600.0%
464
+887.2%
0.00%
Q4 2017$1,0000.0%47
+74.1%
0.00%
Q3 2017$1,000
-66.7%
27
-69.0%
0.00%
Q1 2017$3,000
+50.0%
87
-13.0%
0.00%
Q2 2016$2,000
-50.0%
100
-46.2%
0.00%
-100.0%
Q1 2016$4,000
-81.8%
186
-77.1%
0.00%
-75.0%
Q4 2015$22,0008120.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders